ESR1 and neoplasm: This ability of Brn-3b to cooperate with ERα to enhance gene expression [9], including its own, is clearly relevant to breast cancer because ER-expressing tumours that are responsive to estradiol will stimulate Brn-3b, which can cooperate with ERα to further increase its own expression.